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Most treatments of skin pathologies involve local administration of active agents. One issue can however 
be the partial transcutaneous diffusion of the drug to blood circulation, leading to undesirable effects. 
ln this work, the original use of submicron minerai particles based on bio-inspired calcium phosphate 
apatite was explored for the first time as drug carriers for favoring topical delivery. The permeation of 
a mode( drug across synthetic and biological membranes was investigated in both static and dynamic 
conditions. Our data show that adsorption of the drug on the apatite particles surface drastically lim­
its its permeation, with lower effective diffusion coefficients ( P elî) and smaller total released amounts. 
The retention of the apatite colloïdal particles on porcine ear skin explants surface was demonstrated by 
combining histological observations and Raman confocal microscopy. Ali results converge to show that 
association of the drug to apatite particles favors skin surface effects. These findings point to the rele­
vance of mineral-based particles as drug carriers for (oc.al delivery to the skin, and open the way to nove( 
applications of bio-inspired apatites in dermatology. 
St.atement of Signific.ance 
Calcium phosphates (CaP) are major biomaterials in orthopedics and dentistry. Their resemblance to bone 
minerai allows new applications beyond bone repair, e.g. in nanomedicine. ln 2018, a 14-page detailed 
review (M. Epple, Acta Biomaterialia 77 (2018) 1-14) provided clear facts in favor of the non-toxicity 
of nanosized CaP as an answer to discussions from EU and US study groups, thus clarifying the path 
to nove! applications of nano CaP. ln the present paper, bio-inspired apatite nanoparticles are used for 
the first time as drug carriers for dermatology for drastically limiting drug transcutaneous perme.ation 
and retaining a topical effect. We demonstrate this proof of concept via permeation cell tests, histology,












Skin is an essential natural barrier of the body. lt ensures 
he isolation of internai organs from the external environment -
otentially containing aggressive agents - while allowing major 
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https:JJdoi.org/10.1016/j.actbio2020.05.010 he skin is compromised due to disorders such as eczema, acne, 
soriasis, contact dermatitis, etc., the fundamental roles of this 
utaneous barrier are no more ensured, which may lead to health 
omplications including with the development of pathogenic 
icroorganisms. In the field of dermatology, two types of admin­
stration routes are customarily used to treat such skin disorders 
ia the delivery of active agents: oral and topical (i.e. via direct 
pplication onto the skin). Despite their efficacy to treat the 
utaneous tissue, drugs administered by oral administration are 






























































































































w  rgans (e.g. teratogenicity, articular and muscular pain, dryness,
ltered effectiveness of contraceptive pills, etc. [1 , 2] ). Therefore,
he topical approach is often privileged, at least in a first intention,
ith the objective to directly apply the active agents onto the
ffected site of the dermatosis. 
However, even for topical administration, the permeation of
ctive ingredients (AI) into the blood circulation may occur in
art, thus leading to adverse effects of the drugs as in the sys-
emic route [3] . Transcutaneous drug penetration is dependent
n several factors such as the nature of the AI and its state in
he pharmaceutical formulation. Most galenic products presently
vailable on the market are based on “simply” solubilized active
ngredients which may thus potentially penetrate across the skin
nd up to the blood circulation. 
One appealing approach could be the association of drugs with
arrier particles to focus the therapeutic activity on the surface of
he skin, thus reducing undesirable effects; and carrier particles
an also help to protect unstable AI. In recent years, a considerable
nterest has grown on the use of particles to target hair follicles
or local drug delivery [4] , in link with different pathologies such
s acne, alopecia, hirsutism and hypertrichosis. Particles properties
an be adapted to enhance follicular penetration and one key
actor is their size. Wosicka et al. [4] reported several studies on
articles with different sizes for follicular penetration. Results do
ot necessarily follow a trend due to the different application
echniques used (skin models, application techniques...) and the
ariety of materials. For example, Vogt et al. [5] studied the
enetration of fluorescent polymeric microspheres and showed
hat small particles ( < 40 nm) penetrate deeper into the follicle
han larger particles ( ≥ 750 nm). On the other hand, Patzelt et al.
6] demonstrated that other types of polymer particles with sizes
etween 400 and 700 nm penetrate deeper into pig ear skin than
maller particles. Some studies have focused on lipidic particle
uch as liposomes. Yang et al. [7] studied liposomes to transport
ree fatty acids such as lauric acid with antimicrobial activity
8] ; this vehicle having the advantage of fusing directly with the
embrane of the bacterium to deliver AI directly into it for an
ntibacterial action. Oleosomes were also used, for example by
astro et al. [9] as a vector of retinoic acid, and a comedolytic and
nti-irritant action was pointed out [10 , 11] .
Some studies have also been carried out with inorganic parti-
les, which may exhibit greater chemical and/or physical stability
han organic-based systems. A new process of selective photother-
olysis has recently been published [12] , leading to inorganic
articles based on silica-gold core-shell with a size closed to
50 nm. Under the action of ultrasound, the nanoparticles, that
emained on the surface, penetrated the hair follicle. After laser
rradiation, particle temperature increased and caused sebaceous
lands destruction. Other organic/inorganic materials have been
tudied. AI protection, such as retinoic acid, was the subject of
 study by Perioli et al. [13] , by the use of a hydrotalcite-type
aterial consisting of two-dimensional lamellar hydroxides with
ntegrated anti-inflammatory agents [14] . 
With the view to develop intrinsically-biocompatible inorganic-
ased particles for skin topical action, the present contribution
nvestigates the use of submicron systems based on bio-inspired
alcium phosphate apatites. The bio-inspired character of synthetic
anocrystalline apatites arises from their similarity to the mineral
omponent of bones [15] . Previous works on such apatite colloidal
articles have been carried out in the fields of oncology, hematol-
gy, medical imaging, gene transfection etc. [16 –23] , and pointed
ut their non-cytotoxicity, non-proinflammatory and hemocom-
atible characters in vitro . This aim of this work is to explore the
riginal use of such bio-inspired apatite particles in dermatology,
ith the specific objective to target a superficial effect avoiding
ranscutaneous permeation of the drug. . Materials and methods
.1. Synthesis of bio-inspired apatite colloids 
Colloidal apatite submicron particles were synthesized us-
ng phosphonated polyethyleneglycol (PEG)p as described in a
revious work [19] . Briefly, the apatite precipitation was carried
ut in deionized water, at room temperature and pH 9.5. After
ixing a calcium nitrate solution containing the dispersing agent
PEG)p of molecular weight 5200 Dalton, using a molar ratio
PEG)p / Ca = 0.0016, into a solution of ammonium dihydrogen
hosphate (Ca/P = 0.33), the pH was adjusted to 9.5 by addition
f ammonia. The sample was then placed in a hermetically-closed
ial, in an oven at 100 °C for maturation of 16 h. After this ageing
tep, colloidal suspensions were purified by dialysis process to re-
ove unreacted salts [24] . The final pH of each colloid was finally
djusted to physiological pH with a solution of HCl (0.01 M). For
omparative assessments, as discussed in the text, a non-colloidal
patite sample was also prepared in this study, by following
xactly the same procedure as above, but in the absence of the
PEG)p dispersing agent. 
.2. Physico-chemical characterization of colloidal particles 
The structure of the calcium phosphate particles obtained was
etermined by powder X-ray diffraction using an INEL Equinox
0 0 0 diffractometer, equipped with a curved counter (2 hours
f acquisition), with a cobalt anticathode ( λCo = 1,78892 ̊A). For
omplementary phase characterization, Fourier transform infrared
FTIR) spectroscopy analyses were performed on a Thermo-Nicolet
700 spectrometer with a resolution of 4 cm −1 , in the wavenum-
er range of 400 - 40 0 0 cm −1 , using the KBr pellet method. The
hemical composition of the colloidal samples was investigated
ia atomic absorption spectroscopy (AAS) in flame mode using an
nalytik Jena AG – contrAA 300 high-resolution continuum source
pectrometer. Initial dissolution of the compounds was performed
y acidification with addition of HNO 3 down to pH ~ 2. Dy-
amic light scattering was realized with a Nanosizer ZS apparatus
Malvern Instruments, λ = 630nm) to determine the hydrodynamic
iameter (denoted “particle size” hereafter) of the particles. Trans-
ission Electron Microscopy (TEM) observations were made using
 Hitachi HT 7700 microscope. Solid state NMR 31 P was used to
urther explore the interaction between the surface of apatite par-
icles and the phosphonate endgroup of the (PEG)p molecules used
ere for colloidal stabilization. The NMR spectra were recorded
n a Bruker Avance 400 (9.4T) spectrometer (161.76 MHz, MAS
ode): the samples were placed in 3.2 mm zirconia rotors rotating
t 14 kHz. The experiments were carried out at room temperature.
hemical shifts were determined relatively to 85% H 3 PO 4 . 
.3. Cutaneous application: study of permeation and localization of 
articles 
Skin explants: Ex vivo permeation and localization studies were
arried out on porcine ear skin provided freely for the sake of
esearch by two different local slaughterhouses (Bortigali, Sassari,
taly and Puylaurens, France); the use of skin tissue providing from
lready dead animals is thus in accordance with ethical rules. The
ar skin pre-treatment consisted of washing them with cold water
nd an antibacterial solution (Cytéal®, Pierre Fabre) in order to
inse them and eliminate any impurity. The ears were sheared in
 way to not interfere with the penetration study. The permeation
tudy was carried out on epidermis only. For the permeation
tudy, the ears were soaked in a water bath at 60 °C for 2 minutes
n order to facilitate the separation of epidermis and dermis. They





























































































































gentle pulling [25] . For particle localization assays, biopsies were
prepared with a scalpel to withdraw the whole skin (epidermis,
dermis and hypodermis). Explants were placed at -20 °C until use
( < 1 month). Each skin sample was then examined under an
optical microscope to verify the absence of holes which could alter
the permeation studies. 
2.3.1. Permeation study 
Folic acid (FA) was used as a model drug, adsorbed on the
surface of the (PEG)p-stabilized colloidal particles. The relevance
of selecting FA as a model drug here relies in the easiness to
titrate it by UV spectroscopy (at λ = 280 nm) and to the fact that
adsorption of FA onto the surface of (non-colloidal) biomimetic
apatites was recently proven to be effective [26] . The colloids
were obtained from the reference protocol indicated earlier (part
2.1.), with the only difference of addition of FA in the calcium
salt solution (4,87 mmol of Ca(NO 3 ) 2 .4H 2 O, 0.076 mmol of (PEG)p
and 0.011 mmol of FA in a total volume of 18.75 mL, pH = 9.5),
as previously reported using 2-aminoethylphosphate as stabiliz-
ing agent [21] . After purification by dialysis, the permeation of
these FA-functionalized colloidal apatite particle across synthetic
and biological membranes was compared to permeation of a
simple FA solution with a concentration of 200 mg/L prepared
in a pH = 7.4 buffer medium (KH 2 PO 4 / NaOH, pH ~ 7.4). The
amount of FA permeated at each time point was determined by
data extrapolation using a calibration curve obtained with FA
standard solutions at pH 7.4. The curve was linear in the range
of 0.99 –14.85 mg/L (y = 0.0631x – 0.0088; R 2 0.99999) and
all measurements fell within this range. Sink conditions have
been verified for our static and dynamic permeation studies with
diffusion cells. Several synthetic membranes were used in this
work: two hydrophilic membranes of distinct porosities, 0.05 μm
pore size (polycarbonate) and 0.2 μm (cellulose acetate), and one
hydrophobic membrane (Strat-M®, Merck Millipore). The latter is
constituted of two layers of polyethersulfone (PES) on the surface
of a layer of polyolefin, and is pre-impregnated by synthetic
lipids, creating a porous structure with a gradient of porosity and
susceptible to mimic the partially lipophilic properties of natural
skin [27] . 
Two setups were used in a complementary manner to run the
permeation tests, respectively under static and dynamic condi-
tions. For the static permeation overview, a measurement bench
of six vertical Franz cells (Microette de Hanson), each consisting in
a donor compartment and an accepting compartment (maximum
effective volume 6.7 ml) separated by a membrane, was used at
the Faculty of Pharmacy of Toulouse. The cells were hermetically
closed and thermostated at 32.0 ± 0.5 °C (typical skin surface tem-
perature). The surface area of diffusion was 1.76 cm 2 (membrane
surface of 3.14 cm 2 partially covered by the upper O-ring). Each
recipient compartment was filled with a buffer solution having
a pH close to the physiological value (250 mL of KH 2 PO 4 0.2M
mixed with 195.5 mL of NaOH 0.2M completed with deionized
water to reach 1L) and magnetically stirred. For each sampling
of the solution, over a time period of 48 h, a similar volume of
thermostated buffer was added to maintain the total volume un-
changed. For the dynamic permeation study, permeation test cells
developed at the Department of Chemistry and Pharmacy of the
University of Sassari (Italy) were used [28] . Three permeation cells
(vertical-diffusion type) were mounted in parallel and connected
to a UV-visible spectrophotometer (Shimadzu UV-160A) as in-line
drug monitoring system. As for the static conditions, the whole
system is thermostated to 32.0 ± 0.5 °C. The diffusion area was
of 3.14 cm ². Each cell was slightly raised on one side to avoid air
bubbles directly beneath the membrane. The donor compartments
were partially covered with a plastic stopper in order to avoid
evaporation of the samples analyzed. Each recipient compartmentas filled with the same buffer solution as above, at a pH close
o the physiological value. A magnetic stirrer was placed in the
eceiver compartment, in addition to the peristaltic pump system
o which the cells are connected. The total circulating volume was
ere of 50 mL with a flowrate fixed at 6 mL/min. The diffusion
inetics of a solution of FA alone (200 mg/L) and of FA adsorbed
n the colloidal particles was studied over 2 h (time required for
eaching a steady state), with an initial volume of 1 ml in the
onor compartment. Before use, the skin explants were thawed at
oom temperature and then rehydrated in the medium used in the
ell receptor chamber. The explants were then placed on diffusion
ells. All experiments were carried out at least in triplicate. 
.3.2. Localization of particles on skin samples 
Colloidal apatite particles were here doped with europium ions
u 3 + used so as to follow their localization on skin samples by
hotoluminescence. Colloids were obtained from the reference
rotocol indicated earlier (part 2.1.), with the only difference
f substitution of a part of calcium ions by europium ions in
olution A (Ca(NO 3 ) 2 .4H 2 O + Eu(NO 3 ) 3 .5H 2 O = 4.87 mmol) as
reviously reported for other nanomedicine studies [20 , 29] . After
urification by dialysis, the localization of the colloidal particles
fter application onto porcine ear skin explants was investigated
rom the luminescence signature of Eu 3 + . Comparisons were made
ith a solution of europium nitrate containing free Eu 3 + ions. Skin
amples were used directly after biopsies. The colloidal particles
r the europium solution were applied on the skin samples with
-min manual massage followed by an air drying step at ambient
emperature, to simulate the potential use conditions. Skin sam-
les were then cut, placed in resin-containing molds (Tissue-Tek®
CTTM (Optimum Cutting Temperature)) and then frozen by rapid
reezing in isopentane cooled to -80 °C by an ultra-fast freezing
ystem, Snapfrost®. Serial sections of 5 μm thickness were then
ade using a cryostat (Leica CM 1950), of which half was stained
ith hematoxylin-eosin (HE) for histological observation in order
o be able to locate hair follicles and the other half left uncolored
or observation by confocal Raman microscopy and photolumines-
ence. The histological staining of the samples was carried out
y the CPTP laboratory, Toulouse, France. The staining was carried
ut using a coloring automaton (Leica ST 5020) on the cryo-cuts
rought back to room temperature (4 minutes in a hematoxylin
ath to allow its fixation at the cell nuclei and 2 minutes in a 2%
v/v) eosin solution). After staining, the tissues were dehydrated
n two successive 100 ° ethanol baths, followed by 2 xylene baths,
nd mounted on slats with Eukitt resin. 
The optical analysis of the colored sections was done using
n Olympus BX50F microscope. This analysis was carried out in
rder to identify the hair follicle sections and then to analyze
he sections not colored by confocal Raman microscopy. Raman
pectra were obtained using a Labram HR800 Horiba Jobin Yvon
onfocal microspectrometer on samples exposed to a green laser
ith a wavelength of 532 nm (13 mW, 600 lines/mm). A lens
x100) with a numerical aperture of 0.9 gave a lateral resolution of
.7 μm and an axial resolution of 2.6 μm. The 3D mappings were
ade with a 532 nm 13 mW laser, a 3 μm pitch and an acquisition
ime of 3 s and 1 accumulation. All spectra were processed using
he LabSpec6 software. 
.4. Statistics 
Permeation tests were carried out on a minimum of triplicate
ssays. The reproducibility of batch synthesis was assessed by
unning some permeation experiments on two different batches of
olloidal apatite particles, each in triplicate. Permeation data are
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Fig. 1. XRD patterns for colloidal and non-colloidal apatire particles and for pure (PEG)p (MW 5200 g/mol). The inlet shows a zoom on the 20 = 20-28° range unveiling 

























































. Results and discussion
.1. Colloidal particles characterization 
We have previously reported particle size data on colloids 
tabilized by (PEG)p, around 200 nm for (PEG)p 5200 g/mol before 
urification by dialysis [19). Additional characterization of the 
olloidal particles was performed here after dialysis. First of ail, 
tomic absorption spectroscopy coupled with gravimetric results 
measurement of the dry powder mass obtained after complete 
yophilization of a colloid of 25 ml) allowed us to determine 
he molar ratio between (PEG)p and the apatite phase in these 
olloids, which is of the order of (PEG)p / apatite = 0.12. 
The XRO pattern of the particles stabilized with (PEG)p was 
ecorded after dialysis purification and freeze-drying (Fig. 1 ). 
omparison with a reference pattern for a non-colloidal sam­
le, prepared under same conditions but in the absence of the 
PEG)p dispersing agent, indicates in both cases the presence of a 
oderately-well crystallized apatitic phase (highly similar to that 
f bone minerai [15,301). A slight decrease of crystallinity can be 
bserved for colloidal particles compared to the reference (espe­
ially on peaks (211 ), (112) and (300)). This decrease associated 
ith the presence of (PEG)p during apatite precipitation can be 
valuated by applying the ISO 13779-3: 2008 standard (compared 
o sintered stoichiometric hydroxyapatite), leading to a degree of
rystallinity of 82 ± 4 % for the colloidal particles and 89 ± 5 % for
on-colloidal apatite (reference). lt points out the existence of an 
nteraction between the (PEG)p molecules and the apatite crystals 
n formation during the precipitation stage. The XRD pattern of
he colloid (lyophilized) also shows peaks of the dispersing agent 
(PEG)p as indicated by the comparison with the diagram obtained n the pure (PEG)p reagent (Fig. 1). Application of Scherrer's equa­
ion [31) to peaks (002) and (310) demonstrates the nanometric 
imensions of the crystallites composing the colloidal sample, 
ith an average length along the c axis of the apatite around 
4 ± 2 nm and a mean width/thickness around 12 ± 2 nm. These 
esults thus reveal crystallites of nanometric sizes as in bone 
inerai (biomimetic character [151) for these colloidal particles. 
Complementary assessments were obtained via FTIR spec­
roscopy. As shown in Fig. 2, characteristic apatitic vibration modes 
3 (PO4) and v4CPO4) can easily be identified for the colloidal par­
icles, by comparison to the spectrum obtained on non-colloidal 
patite. Moreover, the characteristic bands of (PEG)p are also 
ound on the FTIR spectrum of colloidal particles as witnessed by 
eference to pure (PEG)p. Nevertheless changes in spectral features 
f colloidal and non-colloidal apatite can be seen: the spectral sig­
ature of apatitic hydroxide ions visible at 3572 cm-1 (vs(OHap)) 
nd 632 cm-1 (v1 (OHap)) is in particular less intense for the colloid
e.g. see zoom in Fig. 2), which could be related to a lower content 
f OH- apatitic ions, suggesting in turn a lower degree of stoi­
hiometry of the apatite phase. This is probably linked to the Iower 
rystallinity evidenced by XRO in Fig. 1, and these data suggest 
ome crystal growth inhibition played by the (PEG)p organic moi­
ty. A decomposition of the FTIR spectrum between 500 and 700 
m-1 of the colloidal particles was carried out using a methodol­
gy previously developed for the study of biomimetic nanocrys­
alline apatites [32) (Fig. 3). Severa) contributions associated to
he vibration of PO43- ions (apatitic typically at 560, 575 and 601
m-1, and not apatitic at 617 cm-1), HPOi- (apatitic at 550 cm-1 
nd not apatitic at 534 cm-1 ), and OH- (632 cm-1) are seen in this
omain. From this decomposition, the area of each contribution
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Fig. 2. FTIR spectra for colloïdal and non-colloidal apatite particles and for pure (PEG)p (MW 5200 g/mol). The inlet shows an enlargement of the 500-700 cm-1 range. 
700 680 660 640 620 600 580 560 540 520 500 
Wavenumbers (cm·1)
Fig. 3. Spectral deconvolution of colloidal apatite particles stabilized by (PEG)p, in 



































oftware. lt is then possible to detennine the relative proportion
ccupied by ions in a given sample. The ratio R of the integrated 




OH-ap+ PO!-ap+ HP�-ap 
Eq. (1) gives the relative proportion of OH- apatitic ions 
ontained in the samples, leading to a value of 0.39 for the on-colloidal reference apatite and 0.29 (after subtraction of the 
ontribution of (PEG)p) for colloidal apatite. These values con­
nn a significant decrease in the proportion of OH- ions in the 
patitic phase obtained by the colloidal route compared to the 
on-colloidal compound. Moreover, the samples prepared here at 
00°c, during 16h (either in the absence or in the presence of 
PEG)p) do not exhibit a significant spectral contribution for 
PO4
2
- ions, as evidenced bY the very low peak area centered on 
34 and 550 cm-1, suggesting that in this work the apatite crystals 
o not exhibit an extended hydrated ionic layer on their surface. 
Solid state 31 P MAS-NMR spectroscopy was used to investigate 
urther the interaction between the phosphonated termination of 
he (PEG)p molecules and the surface of apatite particles. Fig. 4 
hows the spectra obtained for a colloid stabilized with (PEG)p 
200 and for (PEG)p atone. The spectrum relating to (PEG)p alone 
hows the presence of two main peaks at 30.6 and 3.9 ppm. The 
olloidal particles have in contrast an intense peak localized at 2.7 
pm and a large peak of lower intensity with a maximum at 24.2 
pm. The peak at 2.7 ppm is attributed to apatitic phosphates [33). 
he second peak (at 24.2 ppm) cannot be imputed to the phos­
hate ions of apatite and has to be associated to the presence of 
PEG)p, indicating a modification of the spectral signature of this 
olecule when interacting with the surface of apatite particles. 
he initial (PEG)p peak at 30.6 ppm thus appears to be enlarged 
nd shifted to lower chemical shifts, unveiling the existence of a 
trong interaction between the phosphonate group of (PEG) and 
he apatite crystal surface, therefore favoring an orientation of 
he molecule with the phosphonate end-group toward the surface 
f the particles and the organic PEG chain hanging toward the 
olution. 
Fig. 4. NMR 31 P spectra for colloidal apatite stabilized with (PEG)p and for pure (PEG)p (MW 5200 g/mol).
Table 1






0.2 Polyamide (nylon) n.d.



































































The mean hydrodynamic diameter of the colloidal particles was
easured before dialysis, reaching 240 nm with a polydispersity
ndex of 0.22. Measurement performed after dialysis showed a
ownshift to about 180 nm with a lower polydispersity index of
.17. The mean diameter and the polydispersity of the sample were
hus slightly decreased, potentially due to a reorganization of the
rganic corona around the particles (indeed, a partial dissolution
f the particles would have instead been associated to an increase
n particle size due to the partial release of some stabilizing
PEG)p molecules which is not seen here). TEM was tentatively
sed for a more direct observation of the particles; however it
as difficult to find sample preparation conditions (deposition and
rying on the copper grid) and analysis conditions (time under
igh vacuum) that did not alter the particles by provoking their
artial desegregation into smaller pieces (Fig. S1). 
.2. Permeation study across synthetic and biological membranes 
A permeation study was then undergone to check the crossing
f a model drug, Folic Acid (FA) adsorbed on the colloidal particles,
cross synthetic and biological membranes using diffusion cells.
n a first step, Franz cells were used, under static conditions. The
tability of the FA solution in the used buffer solution was pre-
iminarily verified by confirming the steadiness of the absorbance
ver 48 h. Several synthetic membranes were tested here so as
o evaluate the impact of membrane characteristics, such as their
ydrophilicity and porosity, on the permeation of the particles
 Table 1 ). The use of artificial model membranes indeed offers
 simple and reproducible alternative to study the basic physic-chemical mechanisms of drug permeation without the intra-
nd inter-individual variations related to the use of isolated skin
ortions from human or animal origin, as stated by Flaten et al.
34] .
The kinetic permeation study (titrating FA in the recipient
ompartment by UV-vis spectrophotometry) was first carried out
n an FA solution, i.e. in the absence of particles. The data pointed
ut the clear impact of the hydrophilic/lipophilic nature of the test
embranes ( Fig. 5 a): while similar kinetics were found for the
wo hydrophilic membranes (~90% permeation at 24 h), diffusion
hrough the Strat-M® membrane remained very low ( < 5% at the
ame timepoint). Although they have shown a certain capacity
o mimic cutaneous permeation [35] , results may differ from
ata obtained on actual human skin depending on experimental
onditions. In order to allow a more discriminative comparison
f the permeation data obtained in this work using FA as model
rug, hydrophilic synthetic membranes were judged more relevant
or the rest of this study. 
Fig. 5 b reports the permeation data for the two hydrophilic
embranes with both FA solution and the FA-loaded colloidal
patite particles (FA loaded dose: 25 μmol/g). The presence of this
mall amount of FA is not detectable by XRD nor FTIR analyses.
LS analyses after dialysis showed a mean hydrodynamic diameter
f 193 nm. Interestingly, as shown in Fig. 5 b, the diffusion rate was
ound to be significantly reduced for FA adsorbed on the colloidal
articles (plateau reached at ~1500 min) compared to the a solu-
ion of free FA molecules (stabilization around 400 min). Also, the
eleased FA amount reached only an estimate of 34 to 38% for the
olloid as opposed to 90% for the solution. It may be noted that
hese conclusions are valid for both membrane porosities tested.
hese findings thus support the strategy developed in the present
aper, aiming to limit the drug permeation via the preliminary
dsorption onto apatite submicron particles. 
To better quantify the permeation data across the two mem-
ranes, the corresponding effective permeation coefficients P eff
ere calculated (mg.cm −2 .min −1 ) via the equation [36] : 
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Fig. S. a) Penneation of an FA solution (200 mg/Lof h'\ prepared in phosphate bulfer KH2PO. / NaOH, pH - 7.4) across 3 synthetic membranes, in starie conditions. b) 

































where /1 = (dC/dt)ss is the variation of the concentration as a 
unction of time at stationary state (µmol.ml -1 .min-1 ), V is the
olume of the recipient compartment (mL), A is the diffusion 
rea (cm2 ) and C0 the initial concentration in the donor compart­
ent (µmol/mg). The values of Pef! calculated for the diffusion
f the colloidal particles across the membranes with 0.2 µm and 
.05 µm porosities were, respectively, of 0.63.10-3 ± 0.07.10-3 
g.cm-2.min-1 and 0.52.10-3 ± 0.09.10-3 mg.cm-2 .min-1. Oe­
pite large uncertainties on these values, a lower diffusion rate 
ppears to be reached when decreasing the mean porosity of the 
embrane, albeit the diffusion across the 0.05 µm membrane 
emains noticeable. Although OLS gave an averaged mean size 
round 193 nm (supposing a spherical shape), it may be noted 
hat the particles are not expected to be purely spherical as
we previously observed ellipsoidal shapes for colloidal apatite 
particles obtained bY a similar protocol with AEP stabilizing agent 
CIRIMAT laboratory, Toulouse, internai communication), thus 
xposing both a large and a small diameter. Therefore, direct omparison of OLS particle mean size and membrane porosity is 
ot relevant (and TEM analyses led to particle alterations due to 
he high beam energy, making direct observations rather complex 
o achieve without affecting the particles). Nevertheless, these Pef!
alculations allowed us to quantify the effective permeation rates 
eached in the static Franz cells conditions. 
One possible artifact could however be the desorption of a por­
ion of the FA adsorbed amount during the long diffusion time nec­
ssary for this static study. ln order to minimize or eliminate this 
rtifact, we accelerated the diffusion study bY using permeation 
est cells in dynamic conditions as described in the experimental 
ection. Using the same two membranes as for the static study, the 
ermeation of a solution of FA was shown to cross the membranes 
fter 10 min for membrane porosity 0.2 µm and less than 30 min 
r the 0.05 µm membrane, thus considerably faster than above 
 << 400 min) (Fig. S2). The reproducibility of the study was also 
ross-checked bY running experiments on two different batches 
f colloidal apatite particles, each in triplicate, showing highly 


























































t  eproducible data (Fig. S3). For the 0.2 and 0.05 μm membrane
orosities, the calculated effective permeation coefficients were
espectively of 89.00 ± 3.67 and 3.27 ± 0.12 mg.cm −2 .min −1 (the
lateau being reached in about 1 h in such dynamic conditions).
hese data thus validated our objective to obtain much faster
iffusion rates compared to the static mode, and also pointed
o the higher impact of membrane porosity on permeation. The
ynamic setup was thus selected for the rest of the study. 
In order to progress one more step toward the actual situation
f skin permeation, similar dynamic experiments were then car-
ied out on the epidermis layer withdrawn manually from porcine
ar skin explants. The sampling of the epidermis (external part of
he skin only) was cross-checked by histology coloration ( Fig. 6 a),
videncing the absence of dermal sublayers. The permeation of FA
as then studied as above, but on these ex vivo epidermis samples
 Fig. 6 b). Again, fast diffusion was evidenced for FA solution (total
mount diffused in ~20 min). In contrast, and most interestingly,
hen the FA molecules were adsorbed on the colloidal apatite
articles, a drastically slower diffusion was detected across this
pidermis layer. As for the synthetic membranes, these findings
hus demonstrate that having the drug pre-adsorbed onto colloidal
patite particles (as compared to the free solubilized drug) allows
imiting radically its epidermis permeation. In our experimental
onditions, only ca. 10% of FA associated to the particles may cross
he epidermis barrier after 2 h of contact. 
.3. Localization of particles after skin application 
Whether using the static or the dynamic setups, all our per-
eation data evidenced a drastic decrease of the permeation ofhe drug (here modeled by FA) across synthetic and biological
embranes when the drug was associated to the apatite colloidal
articles rather than simply solubilized in the medium. In other
ords, the adsorption of the drug onto the particles surface could
llow, in dermatological applications, to retain the drug on the
kin surface for favoring a topical effect. 
To further demonstrate this point, the localization of apatite
olloidal particles after application onto (unfrozen) porcine ear
kin explants was followed by histological observations coupled to
aman confocal microscopy. To facilitate this analysis, luminescent
u 3 + ions were used as “model drug” and the related photolumi-
escence linked to the 5 D 0 → 7 F 2 transition of Eu 3 + was followed.
ote that only a few mole percents of Ca 2 + ions (~1.5 %) from the
patite particles were substituted by Eu 3 + ions, therefore not mod-
fying the other physical-chemical properties of the particles as
hown previously [29] . Preliminary tests showed that the Raman
pectrum of porcine ear skin did not lead to bands in the 605-627
m −1 domain where Eu 3 + is active. Similar experiments were also
arried out using a solution of europium nitrate to mimic the sit-
ation of a solubilized drug. Fig. 7 reports the results obtained in
hese two scenarios: Eu 3 + simply solubilized and Eu 3 + associated
o the particles. When europium ions were in the dissolved state
n aqueous solution ( Fig. 7 a), a dissemination of these ions was
oticed not only on the skin surface but also in the infundibulum,
he epidermis invagination and in the dermal zone, as witnessed
y the blue staining (artificial color) indicating the position of Eu-
ich domains. Several Eu-rich large islands (red arrows in Fig. 7 a
nd Fig. S4) were observed in this case, traducing significant skin
enetration. The Raman spectral signatures obtained by analyzing
he blue-colored zones indeed showed the typical luminescence
Fig. 7. Coupled histological/Raman/photoluminescence observations of porcine ear skin explants: a) after application of a Eu 3 + solution. b) after application of Eu-doped 
colloidal particles. Images (i) were obtained via histological staining (see experimental section). Images (ii) show the corresponding area by optical microscopy. Images (iii)
show the distributions of chemical species obtained by Raman spectroscopy where the blue coloration (artificial color) shows the location of Eu 3 + . Images (iv) show more 































features of Eu 3 + ions (Fig. S5). In contrast, observations made
when the europium was associated to the particles led to a
localization of the particles noticeably more pronounced on the
skin outer layer and at the entrance of hair follicles ( Fig. 7 b and
Fig. S6). No large island rich in europium was observed in this
case. These data are thus in good agreement with our permeation
studies reported above in static and dynamic conditions on several
synthetic membranes and epidermis, pointing to a preferential
surface localization of a drug if associated to the particles. 
3.4. Discussion 
Orally administered drugs access the blood stream and may be
associated to various side effects. Topical application is thus a rel-
evant therapeutic strategy in dermatology to limit adverse effects
and deliver directly the active components to the skin [37 , 38] .
However, drug permeation may still occur partially, especially ifhe therapeutic treatment needs to be applied over an extended
eriod of time [39] . Also, in the context of a dermatitis like acne,
he relevance of a topical approach is all the more effective that
he pathology is associated with the local development of bacteria
t hair follicles [40] . It thus appears sensible to develop strategies
o restrain the action of the drug (and thus its localization) on
he skin surface. The possibility to deliver the drug directly at
air follicles has been explored with various systems involving
rug nanocarriers [4] , yet the ideal system still needs to be
ound. In this work, we have proposed the use of bio-inspired
alcium phosphates as drug carrier for topical applications. The
articles are composed of nanocrystalline apatite with strong
imilarity to bone mineral [41] and stabilized by phosphonated
olyethyleneglycol (PEG)p. These components are highly biocom-
atible, and the exceptional reactivity of apatite nanoparticles
pens the way to a wealth of applications, well beyond bone

















































































[  In a first part of this work, permeation tests carried out in
tatic and dynamic conditions studies using artificial and biological
porcine epidermis) membranes were run. Our data indicate in
oth cases that association of the drug (here modeled by folic acid,
A) to the apatite nanoparticles drastically reduces the permeated
mount as compared to an FA solution with “free” solubilized
olecules. 
In a second part of the work, we used europium-substituted
patite NPs (europium being used here as a luminescent model
drug”) to investigate the localization of the particles after applica-
ion on porcine ear skin explants. The use of skin explants for der-
atological purposes has been widely developed and used in the
iterature (e.g. [43] ). In our work, in order to follow the particles
ocalization, we developed a strategy coupling histology, Raman
onfocal microscopy and photoluminescence. Our observations
upported the data obtained via permeation tests, suggesting that
ssociation of a drug on the NPs surface significantly reduces skin
enetration, thus favoring a skin surface local effect. Indeed, while
u-rich large islands (red arrows on Fig. 7 a) were observed when
pplying a europium solution onto the skin explants, unveiling sig-
ificant skin penetration, the Eu-loaded particles were essentially
ocalized on the skin outer layer and at the entrance of hair folli-
les ( Fig. 7 b). The strategy developed in this work, using colloidal
patite nanoparticles to deliver drugs to the skin for a local deliv-
ry while limiting skin penetration, is thus found successful. 
. Conclusions
Skin disorders may lead to alterations of the cutaneous barrier,
nd dermatological formulations can be used topically for a local
reatment. In order to limit transcutaneous permeation of the drug
nd related side effects, its association to biocompatible carrier
articles appears particularly adapted. In this work, bio-inspired
patite particles (close to the composition of natural bone mineral)
xhibiting a high intrinsic biocompatibility were considered for
he first time as possible drug carriers for favoring topical skin
dministration in view of dermatological applications to treat
uch dermatoses. Using both folic acid and europium as “model
rugs”, our data (in terms of drug permeation across synthetic
nd biological membranes as well as particle localization after
kin administration) converge to show that association of the drug
o apatite particles may significantly favor skin surface effects.
hese findings open the way to novel applications of bio-inspired
alcium phosphate apatites in the field of dermatology, and par-
icipate to show the relevance of mineral-based particles as drug
arriers for local delivery to the skin. 
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